Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumors.

Abstract:

:We have applied a triple combination of 5-fluorouracil (5FU), vitamin A and cobalt-60 radiation (FAR therapy) to clinical treatment of head and neck tumors since 1972. The treatment of 33 patients with cancer of larynx and 15 patients with hypopharyngeal or cervical esophageal cancer with FAR therapy during three years from 1972 to 1974 resulted in highly effective synergism in vivo, and the improved points of this therapy were presented.

journal_name

Oncology

journal_title

Oncology

authors

Komiyama S,Hiroto I,Ryu S,Nakashima T,Kuwano M,Endo H

doi

10.1159/000225299

subject

Has Abstract

pub_date

1978-01-01 00:00:00

pages

253-7

issue

6

eissn

0030-2414

issn

1423-0232

journal_volume

35

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • Clinical characteristics and outcomes of lung cancer with pulmonary embolism.

    abstract:BACKGROUND:Cancer patients have a higher risk for thrombosis that is usually related to advanced stage and poor prognosis. This study aimed to identify the clinical picture and outcome of non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) patients with pulmonary embolism (PE). PATIENTS AND METHODS:Fr...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000229503

    authors: Chuang YM,Yu CJ

    更新日期:2009-01-01 00:00:00

  • Preoperative serum alpha-L-fucosidase activity as a prognostic marker in colorectal cancer.

    abstract:OBJECTIVES:The aim of this study was to examine the prognostic value of the preoperative serum alpha-L-fucosidase (AFU) activity in colorectal cancer and to assess whether it could add prognostic information that Dukes' stages do not give. METHODS:A postoperative follow-up of 137 colorectal cancer patients was perform...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000066521

    authors: Ayude D,Páez De La Cadena M,Martínez-Zorzano VS,Fernández-Briera A,Rodríguez-Berrocal FJ

    更新日期:2003-01-01 00:00:00

  • Reduced expression of manganese superoxide dismutase mRNA may correlate with invasiveness in esophageal carcinoma.

    abstract::Little is known about the expression and antioxidant function of manganese superoxide dismutase (Mn-SOD) in esophageal squamous cell carcinoma. To determine the significance of Mn-SOD in esophageal squamous cell carcinomas, Mn-SOD mRNA expression was examined in 45 esophageal squamous cell carcinomas and the correspon...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012165

    authors: Toh Y,Kuninaka S,Mori M,Oshiro T,Ikeda Y,Nakashima H,Baba H,Kohnoe S,Okamura T,Sugimachi K

    更新日期:2000-09-01 00:00:00

  • Effect of canthaxanthin on chemically induced mammary carcinogenesis.

    abstract::Canthaxanthin, a carotenoid with no vitamin A activity, was evaluated for its efficacy in the prevention of chemically induced mammary cancers. Canthaxanthin was administered in the diet at two dose levels (3,390 or 1,130 mg/kg diet). In the dimethylbenzanthracene-induced mammary cancer model, diet supplementation wit...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226935

    authors: Grubbs CJ,Eto I,Juliana MM,Whitaker LM

    更新日期:1991-01-01 00:00:00

  • Influence of adriamycin on growth kinetics of Lewis lung carcinoma and its lung metastases.

    abstract::Using a Gompertzian pharmacodynamic model, we have studied the changes induced by graded doses of adriamycin (AM) on the growth of intramuscular Lewis lung carcinoma (3LL) and its lung metastases in C57Bl/6 mice. An interpretation of the drug's effects on free growth of the tumor cells is given in the Appendix. Unlike...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225709

    authors: Madonna M,Colombo T,Donelli MG,Dagnino G

    更新日期:1983-01-01 00:00:00

  • Immuno-Oncological Treatment and Tumor Mass in Non-Small Cell Lung Cancer: Case-Control Analysis of Overall Survival in Routine Clinical Practice.

    abstract:BACKGROUND:Immuno-oncological (IO) therapies such as PD-1 and PD-L1 antibodies have been introduced in the treatment of advanced non-small cell lung cancer (NSCLC) since 2015 based on randomized trials showing unprecedented advantages in overall survival (OS) with hazard ratios (HRs) between 0.5 and 0.7. The impact of ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000500885

    authors: Faehling M,Kopp M,Schwenk B,Fallscheer S,Kramberg S,Eckert R

    更新日期:2019-01-01 00:00:00

  • Elevation of Neutrophil-to-Lymphocyte Ratio before First-Line Chemotherapy Predicts a Poor Prognosis for Second-Line Chemotherapy in Gastric Cancer.

    abstract:OBJECTIVES:The neutrophil-to-lymphocyte ratio (NLR) has been proposed as an indicator of cancer-related inflammation. The aim of our study was to examine the prognostic value of the NLR for patients with advanced gastric cancer receiving second-line chemotherapy. METHODS:The association of overall survival (OS) in sec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000493427

    authors: Inoue D,Sekiguchi S,Yamagata W,Maeda G,Yamada D,Fujiwara S,Itou S,Kurihara M,Hijioka Y,Shimoji K,Fujiki J,Nakazono A,Horike H,Yoshioka A,Ogura Y,Hatao F,Imamura K,Namiki S

    更新日期:2019-01-01 00:00:00

  • Cyclin D3 expression, cell proliferation and pathological stage of human primary colorectal cancer.

    abstract::Cyclin D3 promotes cell cycle progression but its expression and prognostic significance in human colorectal cancer is unknown. This study assayed cyclin D3 expression against cell cycle phase fraction and Duke's stage in 35 fresh human primary colorectal cancers. DNA content, cell cycle phase fraction and cyclin D3 e...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011932

    authors: Watson DS,Brotherick I,Shenton BK,Wilson RG,Angus B,Varma JS,Campbell FC

    更新日期:1999-01-01 00:00:00

  • Palliative chemotherapy in non-Hodgkin's lymphoma.

    abstract:GOALS OF WORK:There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin's lymphoma (NHL) patients who relapse after conventional or high-dose chemotherapy. The aim of this study was to investigate the feasibility and efficacy of peroral chemotherapy in the palliative treatment ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227672

    authors: Salminen E,Nikkanen V,Lindholm L

    更新日期:1997-03-01 00:00:00

  • Relation between delay and survival in 596 patients with breast cancer.

    abstract::To evaluate the influence of delay between first symptom and first treatment upon survival the medical records of 596 patients with breast cancer were reviewed. The following intervals were considered: less than 3 months; 3-6 months and greater than 6 months. Patients in the less than 3 months delay group had a better...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226689

    authors: Machiavelli M,Leone B,Romero A,Perez J,Vallejo C,Bianco A,Rodriguez R,Estevez R,Chacon R,Dansky C

    更新日期:1989-01-01 00:00:00

  • Combined determination of serum CA 19-9 and tissue polypeptide antigen: why no improvement in pancreatic cancer diagnosis?

    abstract::CA 19-9 and tissue polypeptide antigen (TPA) were determined in the sera of 28 control subjects, 29 patients with pancreatic cancer, 26 with chronic pancreatitis and 62 with benign and malignant extra pancreatic diseases in order to compare their usefulness in diagnosing pancreatic cancer, to verify whether the combin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226525

    authors: Basso D,Fabris C,Del Favero G,Panucci A,Plebani M,Angonese C,Leandro G,Dodi G,Burlina A,Naccarato R

    更新日期:1988-01-01 00:00:00

  • Combination chemotherapy of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with brain metastases from non-small cell lung cancer.

    abstract:BACKGROUND:Brain metastases develop frequently in patients with non-small cell lung cancer (NSCLC), and the prognosis for these patients is very poor. We evaluated the role of chemotherapy for patients with brain metastases from NSCLC. METHODS:We analyzed 30 patients who were discovered to have brain metastases during...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000012185

    authors: Fujita A,Fukuoka S,Takabatake H,Tagaki S,Sekine K

    更新日期:2000-11-01 00:00:00

  • Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis.

    abstract::Calcitriol (1,25-dihydroxycholecalciferol) has antiproliferative and/or proapoptotic effects on many cell types and the glucocorticoid dexamethasone enhances these effects. We have shown that calcitriol modulates several key signaling proteins involved in differentiation, proliferation and apoptosis in tumor-derived m...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000098872

    authors: Flynn G,Chung I,Yu WD,Romano M,Modzelewski RA,Johnson CS,Trump DL

    更新日期:2006-01-01 00:00:00

  • Clinical implications of expression of ETS-1 related to angiogenesis in metastatic lesions of ovarian cancers.

    abstract:OBJECTIVE:ETS-1 has been identified as a proto-oncogene and a transcription factor for tumor angiogenesis, which is essential for the growth, invasion and metastasis of solid tumors. The aim is to investigate the clinical implications of ETS-1 expression in peritoneal metastatic lesions of ovarian cancers. METHODS:In ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000079491

    authors: Fujimoto J,Aoki I,Toyoki H,Khatun S,Sato E,Sakaguchi H,Tamaya T

    更新日期:2004-01-01 00:00:00

  • Aspirin shares a short-term effect, inhibition of pyruvate kinase activity with tumor-promoting agents, but fails to promote rat liver carcinogenesis.

    abstract::Since aspirin was found to cause a persistent decrease in pyruvate kinase activity, which is a prominent characteristic of the hepatic promoters, the effect of aspirin on hepatic tumorigenesis in the rat has been studied. Male Wistar rats were initiated with a diet containing 0.06% 3'-methyl-4-dimethylamino-azobenzene...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227195

    authors: Yanagi S,Yamashita M,Hiasa Y

    更新日期:1993-07-01 00:00:00

  • Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis.

    abstract:BACKGROUND:Clinical significance of immunohistochemically detectable level of p53 protein has been reported, but with some limitation as a prognosticator of bladder cancer patients. Whether or not simultaneous evaluation of mdm2 and p53 expression in bladder cancer exceed the prognostic significance of conventional his...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011971

    authors: Shiina H,Igawa M,Shigeno K,Yamasaki Y,Urakami S,Yoneda T,Wada Y,Honda S,Nagasaki M

    更新日期:1999-04-01 00:00:00

  • Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies.

    abstract:PURPOSE:This phase I study (EudraCT No. 2006-001177-25) investigated aflibercept, a vascular endothelial growth factor decoy receptor protein (VEGF Trap), in combination with docetaxel, cisplatin, and 5-fluorouracil in patients with advanced solid tumors. PATIENTS AND METHODS:Patients received 2, 4, or 6 mg/kg of intr...

    journal_title:Oncology

    pub_type: 杂志文章,多中心研究

    doi:10.1159/000440958

    authors: Bahleda R,Baker J,Massard C,Gadgeel SM,Rogers JE,Izzedine H,Deutsch E,Garris JL,Khan A,Boelle E,Assadourian S,Soria JC,Ajani JA

    更新日期:2016-01-01 00:00:00

  • Reintroduction of oxaliplatin: a viable approach to the long-term management of metastatic colorectal cancer.

    abstract::Oxaliplatin-based chemotherapy is an effective first-line treatment option for patients with metastatic colorectal cancer (mCRC), which, in combination with targeted therapies and a sequential treatment approach using all active agents, has extended median overall survival to 2 years and beyond. Prolonged survival bri...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000323491

    authors: Grothey A

    更新日期:2010-01-01 00:00:00

  • Side effects of ifosfamide.

    abstract::Ifosfamide is relatively well tolerated but it can be associated occasionally with life-threatening complications such as arrhythmias and heart failure, severe encephalopathy and hemorrhagic cystitis. Mesna administration can control the urothelial toxicity of ifosfamide, but it is without effect on the other complica...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000073351

    authors: Klastersky J

    更新日期:2003-01-01 00:00:00

  • Increased antitumor activity in combined treatment TS-1 and docetaxel. A preclinical study using gastric cancer xenografts.

    abstract::As TS-1 and docetaxel (TXT) have different mechanisms of antitumor activity, the combination therapy is expected to have a higher response. Human gastric cancer xenografts SC-2, St-40, and SC-4 inoculated into nude rats were treated with TS-1 alone (TS-1 12 mg/kg/day, day 1-14), TXT alone (TXT 2 mg/kg/day, day 1 or da...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000086767

    authors: Takahashi I,Emi Y,Kakeji Y,Uchida J,Fukushima M,Maehara Y

    更新日期:2005-01-01 00:00:00

  • Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers.

    abstract::C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive methods such as radioimmunoassay. Patients with some tumors appear to have much higher serum levels of CRP than others; in these, CRP seems to reflect the tumor burden. There is a positive correlation with TNM stagin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225572

    authors: Drahovsky D,Dunzendorfer U,Ziegenhagen G,Drahovsky M,Kellen JA

    更新日期:1981-01-01 00:00:00

  • Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective comparison with previously known prognostic models.

    abstract:BACKGROUND:Sorafenib, a multitargeted tyrosine kinase inhibitor, is now the treatment of choice for systemic therapy of patients with advanced hepatocellular carcinoma (HCC). Herein, we present the clinical characteristics and outcomes of patients with advanced HCC who were treated with sorafenib. METHODS:Data of 201 ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000327591

    authors: Baek KK,Kim JH,Uhm JE,Park SH,Lee J,Park JO,Park YS,Kang WK,Lim HY

    更新日期:2011-01-01 00:00:00

  • Serum Exosomal Gamma-Glutamyltransferase Activity Increased in Patients with Renal Cell Carcinoma with Advanced Clinicopathological Features.

    abstract:BACKGROUND:There has been no clinically useful diagnostic or prognostic biomarker for renal cell carcinoma (RCC). Serum γ-glutamyltransferase (GGT) activity has been reported to be a prognostic marker for several types of cancer including RCC. Exosomes or small extracellular vesicles present in body fluids have potenti...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508688

    authors: Horie K,Kawakami K,Fujita Y,Matsuda Y,Arai T,Suzui N,Miyazaki T,Koie T,Mizutani K,Ito M

    更新日期:2020-01-01 00:00:00

  • Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: no adjuvant treatment following radical surgery.

    abstract::The paper presents the experience with watch-and-wait policy following radical surgery in 25 patients with primary gastric non-Hodgkin's (NH) lymphoma localized to the gastric wall. The median follow-up is at the moment 40 months (range 18-85). Only 3/25 patients have relapsed (during the first year of the follow-up) ...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000227347

    authors: Jelić S,Kovcin V,Jovanović V,Oprić M,Milanović N

    更新日期:1994-05-01 00:00:00

  • Elliptinium acetate in metastatic breast cancer--a phase II study.

    abstract::Thirty-five patients with metastatic breast cancer who had received one or two prior chemotherapeutic regimens were treated with elliptinium acetate at a dose of 80 mg/m2 for 3 days every 3 weeks. Of the 33 patients evaluable for response, 1 patient achieved complete remission, 4 achieved partial responses (15% overal...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226797

    authors: Buzdar AU,Hortobagyi GN,Esparza LT,Holmes FA,Ro JS,Fraschini G,Lichtiger B

    更新日期:1990-01-01 00:00:00

  • Effect of reoxygenation on the hypoxia-induced up-regulation of serine protease inhibitor PAI-1 in head and neck cancer cells.

    abstract::In squamous cell carcinoma of the head and neck (SCCHN), hypoxia is considered a crucial physiological modulator for malignant progression, wherebythe plasminogen activation system is involved in overlapping functions such as moulding of the extracellular matrix, cell proliferation and signal transduction. Little is k...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000106789

    authors: Sprague LD,Mengele K,Schilling D,Geurts-Moespot A,Sweep FC,Stadler P,Schmitt M,Molls M

    更新日期:2006-01-01 00:00:00

  • Cells from normal and malignant human colon mucosa differentially inhibit embryonic cell aggregation.

    abstract::A model system for studying some aspects of the interaction of cancer cells in tumors and their surrounding nonmalignant tissue is the co-culture of cancer cells and embryonic chick neural retinal cells in gyratory shakers. Neural retina cell aggregation, under these conditions, has been shown to be differentially inh...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225573

    authors: Maslow DE,Mayhew E,Mittleman A

    更新日期:1981-01-01 00:00:00

  • Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.

    abstract:BACKGROUND:HER2 positivity is reported to be <20% in gastric cancer. Clinicopathological characteristics will be helpful to understand the biological features of HER2-positive gastric cancer. METHODS:A total of 813 gastric cancer patients who underwent HER2 testing between January 2005 and December 2010 were included ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000368555

    authors: Park JS,Rha SY,Chung HC,Jung M,Kim KH,Jun HJ,Kim H,An JY,Kim HI,Cheong JH,Hyung WJ,Noh SH,Kim HS

    更新日期:2015-01-01 00:00:00

  • Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma.

    abstract:OBJECTIVES:It was the aim of this study to evaluate clinicopathological characteristics and prognostic factors of uterine leiomyosarcomas (LMS). METHODS:Twenty-eight patients with uterine LMS were evaluated in this retrospective study. Their features and survival were analyzed by Kaplan-Meier and log-rank tests. RESU...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000331679

    authors: Loizzi V,Cormio G,Nestola D,Falagario M,Surgo A,Camporeale A,Putignano G,Selvaggi L

    更新日期:2011-01-01 00:00:00

  • Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.

    abstract:OBJECTIVES:Low body mass index (BMI) and/or low lean body mass have been shown to be risk factors for chemotherapy-related toxicities in a number of different cancers. However, no data are available regarding the role of BMI as a risk factor for developing toxicities related to the novel anticancer agent, trabectedin, ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000487266

    authors: Vincenzi B,Badalamenti G,Armento G,Silletta M,Spalato Ceruso M,Catania G,Napolitano A,Maltese G,Valeri S,Incorvaia L,Santini D,Tonini G

    更新日期:2018-01-01 00:00:00